Proteomics Market Size is valued at 36.63 billion in 2024 and is predicted to reach 132.74 billion by the year 2034 at a 14.0% CAGR during the forecast period for 2025-2034.
Proteomics is the most advanced area of disease diagnostics, which is changing quickly. Proteomics is utilized to identify the proteins present in a specific disease and aids in comprehending both their expression and function. Due to the rising rapid market growth in the amount of technical and financial effort put into research and development activities, numerous new technologies are anticipated to be introduced into proteomics.
The need for proteomics is anticipated to develop dramatically in the upcoming years due to the recent rise in cancer cases and the huge increase in the prevalence of genetic disorders. The development of biomarkers, clinical diagnostics, and an increased focus on product features in drug design will all contribute to market expansion.
Moreover, the protein research being done to treat COVID-19 patients is fueling market expansion. In addition, a study in Nature Chemical Biology found that tiny proteins can prevent virus entry into human cells and group virus particles collectively to lessen the virus's capacity for infection. Additionally, the COVID-19 pandemic is anticipated to spur an increase in peptide therapeutic research, which will benefit the industry. Additionally, market expansion over the anticipated period is being driven by increased public and private funding for proteome research.
The proteomics market is segmented based on product and application. Based on product, the proteomics market is segmented as spectrometry, chromatography, electrophoresis, x-ray crystallography, surface plasmon resonance, x-ray crystallography, protein fractionation systems, etc. By reagents, the market is segmented into immunoassay reagents, spectroscopy reagents, chromatography reagents, protein microarray reagents, x-ray crystallography reagents, electrophoresis reagents and protein fractionation reagents. By software & services, the market is segmented as core proteomics services and bioinformatics software & services. The market is segmented by application as diagnostic, drug discovery & development, and others. End users segment the market as hospitals, labs and biopharma.
The spectroscopy category will hold a major share of the global Proteomics market 2022. The market will expand due to the widespread use of this technology in most processes and its significant applications in the production of medications, foreign illness analysis, pharmaceutical analysis, and proteomics metabolomics. The most widely popular method in the world and has had substantial growth in recent years since it helps synthesize medications through various procedures.
The clinical diagnosis segment is projected to grow rapidly in the global Proteomics market. Researchers and doctors frequently employ protein analysis to find disease biomarkers for early detection and identifying specific risk factors. New opportunities for illness early identification and prevention should result from this. Proteomics-based diagnostics, which supports the segment's expansion, makes it possible to uncover potential biomarkers and protein transcriptional regulation that may be used to recognize and predict cancers and assess their prognosis.
In the upcoming years, the early diagnosis of numerous diseases will be a significant opportunity for developing this approach. The use of proteomics can be used to understand biomarkers. Additionally, it aids in the recognition and categorization of tumors.
The North America Proteomics market is expected to register the highest market share. Antibody-drug conjugates and protein therapies are important in treating and diagnosing diseases in North America. This subject is constantly developing, and there has been a substantial study on cutting-edge, revolutionary next-generation treatments. More than a hundred modified therapeutic proteins have been approved for clinical application. Several protein therapies are undergoing clinical trials to treat cancer, immunological disorders, infections, age-related diseases, and numerous other ailments.
Additionally, proteomics research is most active in nations like the United States. In addition, the Europe regional market is projected to grow rapidly in the global proteomics market. This market will expand due to ongoing field research and development and the utilization of top-notch instruments for research. There will be a massive increase in the demand for proteomics due to the rising demand for customized medicines or treatments. Ongoing partnerships and collaborations among the various market participants will also assist the market's expansion.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 36.63 Bn |
|
Revenue Forecast In 2034 |
USD 132.74 Bn |
|
Growth Rate CAGR |
CAGR of 14.0% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
Type Of Technology, Product, Application, And End User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; South Korea; South East Asia |
|
Competitive Landscape |
Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), and Waters Corporation (US). |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Proteomics Market Snapshot
Chapter 4. Global Proteomics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Metaverse Industry
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact on Metaverse Industry
Chapter 5. Market Segmentation 1: By Instrumentation Technologies Estimates & Trend Analysis
5.1. By Instrumentation Technologies & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Instrumentation Technologies:
5.2.1. Spectroscopy
5.2.1.1. Mass Spectrometry
5.2.1.2. NMR Spectroscopy
5.2.1.3. CD Spectroscopy
5.2.2. Chromatography
5.2.2.1. HPLC Chromatography
5.2.2.2. Ion Chromatography
5.2.2.3. Affinity Chromatography
5.2.2.4. Superficial Chromatography
5.2.3. Electrophoresis
5.2.3.1. Gel Electrophoresis
5.2.3.2. Capillary Electrophoresis
5.2.4. Protein Microarrays
5.2.4.1. Biochips
5.2.4.2. Microarray Instruments
5.2.5. X-Ray Crystallography
5.2.6. Surface Plasmon Resonance
5.2.7. Protein Fractionation
5.2.8. Other Technologies Other Material Proteomics
Chapter 6. Market Segmentation 2: By Reagent Estimates & Trend Analysis
6.1. By Instrumentation Technologies & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Reagent :
6.2.1. Immunoassay Reagents
6.2.2. Spectroscopy Reagents
6.2.3. Chromatography Reagents
6.2.4. Protein Microarray Reagents
6.2.5. X-Ray Crystallography Reagents
6.2.6. Electrophoresis Reagents
6.2.7. Protein Fractionation Reagents
6.2.8. Other Reagents (Edman's reagent, enzymes, cross-linking agents)
Chapter 7. Market Segmentation 3: By Software & Services Estimates & Trend Analysis
7.1. By Instrumentation Technologies & Market Share, 2024-2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Software & Services:
7.2.1. Core Proteomics Services
7.2.2. Bioinformatics Software & Services
Chapter 8. Market Segmentation 4: By Application Estimates & Trend Analysis
8.1. By Instrumentation Technologies & Market Share, 2024-2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application:
8.2.1. Clinical Diagnostics
8.2.2. Drug Discovery & Development
8.2.3. Other Applications
Chapter 9. Market Segmentation 5: By End-User Estimates & Trend Analysis
9.1. By Instrumentation Technologies & Market Share, 2024-2034
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-User:
9.2.1. Hospitals
9.2.2. Clinical Laboratories
9.2.3. Pharmaceutical & Biotechnology Companies
9.2.4. Academic Research Laboratories
9.2.5. Other End Users
Chapter 10. Proteomics Market Segmentation 10: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Proteomics Market revenue (US$ Million) estimates and forecasts By Instrumentation Technologies, 2021-2034
10.1.2. North America Proteomics Market revenue (US$ Million) estimates and forecasts By Reagent , 2021-2034
10.1.3. North America Proteomics Market revenue (US$ Million) estimates and forecasts By Software & Services, 2021-2034
10.1.4. North America Proteomics Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
10.1.5. North America Proteomics Market revenue (US$ Million) estimates and forecasts By End-User, 2021-2034
10.1.6. North America Proteomics Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
10.1.6.1. U.S.
10.1.6.2. Canada
10.2. Europe
10.2.1. Europe Proteomics Market revenue (US$ Million) by By Instrumentation Technologies, 2021-2034
10.2.2. Europe Proteomics Market revenue (US$ Million) estimates and forecasts By Reagent , 2021-2034
10.2.3. Europe Proteomics Market revenue (US$ Million) estimates and forecasts By Software & Services, 2021-2034
10.2.4. Europe Proteomics Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
10.2.5. Europe Proteomics Market revenue (US$ Million) estimates and forecasts By End-User, 2021-2034
10.2.6. Europe Proteomics Market revenue (US$ Million) by country, 2021-2034
10.2.6.1. Germany
10.2.6.2. Poland
10.2.6.3. France
10.2.6.4. Italy
10.2.6.5. Spain
10.2.6.6. UK
10.2.6.7. Rest of Europe
10.3. Asia Pacific
10.3.1. Asia Pacific Proteomics Market revenue (US$ Million) by By Instrumentation Technologies, 2021-2034
10.3.2. Asia Pacific Proteomics Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
10.3.3. Asia Pacific Proteomics Market revenue (US$ Million) estimates and forecasts By Reagent , 2021-2034
10.3.4. Asia Pacific Proteomics Market revenue (US$ Million) estimates and forecasts By Software & Services, 2021-2034
10.3.5. Asia Pacific Proteomics Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
10.3.6. Asia Pacific Proteomics Market revenue (US$ Million) estimates and forecasts By End-User, 2021-2034
10.3.7. Asia Pacific Proteomics Market revenue (US$ Million) by country, 2021-2034
10.3.7.1. China
10.3.7.2. India
10.3.7.3. Japan
10.3.7.4. Australia
10.3.7.5. Rest of Asia Pacific
10.4. Latin America
10.4.1. Latin America Proteomics Market revenue (US$ Million) by By Instrumentation Technologies, 2021-2034
10.4.2. Latin America Proteomics Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
10.4.3. Latin America Proteomics Market revenue (US$ Million) estimates and forecasts By Reagent , 2021-2034
10.4.4. Latin America Proteomics Market revenue (US$ Million) estimates and forecasts By Software & Services, 2021-2034
10.4.5. Latin America Proteomics Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
10.4.6. Latin America Proteomics Market revenue (US$ Million) estimates and forecasts By End-User, 2021-2034
10.4.7. Latin America Proteomics Market revenue (US$ Million) by country, (US$ Million) 2021-2034
10.4.7.1. Brazil
10.4.7.2. Rest of Latin America
10.5. Middle East & Africa
10.5.1. Middle East & Africa Proteomics Market revenue (US$ Million) by By Instrumentation Technologies, (US$ Million)
10.5.2. Middle East & Africa Proteomics Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
10.5.3. Middle East & Africa Proteomics Market revenue (US$ Million) estimates and forecasts By Reagent , 2021-2034
10.5.4. Middle East & Africa Proteomics Market revenue (US$ Million) estimates and forecasts By Software & Services, 2021-2034
10.5.5. Middle East & Africa Proteomics Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
10.5.6. Middle East & Africa Proteomics Market revenue (US$ Million) estimates and forecasts By End-User, 2021-2034
10.5.7. Middle East & Africa Proteomics Market revenue (US$ Million) by country, (US$ Million) 2021-2034
10.5.7.1. South Africa
10.5.7.2. GCC Countries
10.5.7.3. Rest of MEA
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Thermo Fisher Scientific, Inc. (US),
11.2.2. Danaher Corporation (US),
11.2.3. Merck KGaA (Germany),
11.2.4. Agilent Technologies, Inc. (US),
11.2.5. Waters Corporation (US).
Segmentation of Proteomics Market-
Proteomics Market By Product-
Proteomics Market By Regents
Proteomics Market By Software & Services
Proteomics Market By Application-
Proteomics Market By End users
Proteomics Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
